Safety and Immunogenicity Study of a Bivalent Vaccine for Combined Prophylaxis of COVID-19 and Influenza in Non-Human Primates

Background. Influenza and SARS-CoV-2 viruses are two highly variable pathogens. We have developed a candidate bivalent live vaccine based on the strain of licensed A/Leningrad/17-based cold-adapted live attenuated influenza vaccine (LAIV) of H3N2 subtype, which expressed SARS-CoV-2 immunogenic T-cel...

Descrición completa

Detalles Bibliográficos

Principais autores:	Ekaterina Stepanova, Irina Isakova-Sivak, Victoria Matyushenko, Daria Mezhenskaya, Igor Kudryavtsev, Arina Kostromitina, Anna Chistiakova, Alexandra Rak, Ekaterina Bazhenova, Polina Prokopenko, Tatiana Kotomina, Svetlana Donina, Vlada Novitskaya, Konstantin Sivak, Dzhina Karal-Ogly, Larisa Rudenko
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2024-09-01
Series:	Vaccines
Assuntos:	SARS-CoV-2 influenza bivalent vaccine virus-vectored vaccine non-human primates rhesus monkeys
Acceso en liña:	https://www.mdpi.com/2076-393X/12/10/1099
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!